Clinical trial

Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)

South West Sydney Local Health DistrictNot yet recruitingPhase 1Started Dec 10, 202520 enrolledAustraliaNCT07247370

Abstract

To assess the safety, feasibility and preliminary efficacy of ketamine-enhanced therapy (KET) for alcohol use disorder (AUD) and comorbid major depressive disorder (MDD) in an open-label, single arm, pilot clinical trial.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetamineDepressionAddiction

Keywords

Ketamine-enhanced psychotherapyOpen-labelSingle-armConcurrent Treatment of AUD and comorbid MDDAlcohol Use Disorder (AUD)Major Depressive Disorder (MDD)Alcohol Use Disorder (AUD)Major Depressive Disorder (MDD)Comorbidities and Coexisting Conditions

View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

ArticleKetamine

Ketamine Assisted Psychotherapy: A Systematic Narrative Review of the Literature.

Drozdz SJ, Goel A, McGarr MW +6

Europe PMC2022

ArticleKetamine

Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study.

Chiappini S, d'Andrea G, De Filippis S +10

Europe PMC2023

ArticleMDMA

Prevalence and Psychiatric Correlates of Illicit Substance Use in UK Undergraduate Students.

Foster H, Stevenson J, Akram U

Europe PMC2023